The UCSF Helen Diller Family Comprehensive Cancer Center brings experts from across cancer specialties within UCSF’s network and beyond to revolutionize how cancer is treated. UCSF Parker Institute investigators continue building on the university’s deep scientific expertise to advance research in T-cell therapies, CRISPR technology, the biology of the immune microenvironment and precision treatments. Kole Roybal, PhD | Director Julia Carnevale, MD | Co-Director All Investigators Related Press Release PICI, JDRF and Helmsley Trust Form Research Initiative Announcement PICI Young Investigator Retreat 2019 Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto Research Update Cancer Vaccines: A New Era in Cancer Treatment Announcement, Press Release Dr. Sager Named Recipient of PICI’s Inaugural YIA Award Announcement, Press Release PICI Brings Power of Integrated Network to ASCO 2026 Announcement, Press Release PICI Welcomes Aimee Johnson as Chief Marketing Officer Announcement, Press Release PICI Network Shapes Future of Immunotherapy at AACR 202 Announcement, Press Release PICI and CVC Unite to Accelerate Cancer Vaccines